drugset / Trial / NCT00668044

Ciprofloxacin on Burned Patients

NCT00668044

Phase 3 Completed 18 enrolled Bayer
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This was a non randomised, multi center, italian study performed in burn patients receiving an antibiotic (ciprofloxacin) in order to treat an active infection. The aim of the study was to validate a pharmacokinetics model useful to verify if a standard dose regimen of ciprofloxacin, given to patients with a compromised metabolism, is a correct dose or instead is over or under dosed.

Timeline

Start
2002-11
Primary completion
2003-11
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 400 mg Intravenous